Alpha 2.0
Login Register
» Articles » PMID: 23426493

Intralesional Immunotherapy with Mycobacterium W Vaccine in Patients with Multiple Cutaneous Warts: Uncontrolled Open Study

Overview
Journal JAMA Dermatol
Publisher American Medical Association
Specialty Dermatology
Date 2013 Feb 22
PMID 23426493
Citations 10
Authors
Jitendra K Meena
Amit K Malhotra
Deepak K Mathur
Dinesh C Mathur
Affiliations
Soon will be listed here.
Citing Articles

promising immunotherapeutic intervention for diseases.

Stefan K, Gordon R, Rolig A, Honkala A, Tailor D, Davis L Front Immunol. 2024; 15:1450118.

PMID: 39534596 PMC: 11554463. DOI: 10.3389/fimmu.2024.1450118.

(MIP) Vaccine: Pharmacology, Indication, Dosing Schedules, Administration, and Side Effects in Clinical Practice.

Dogra S, Jain S, Sharma A, Chhabra S, Narang T Indian Dermatol Online J. 2023; 14(6):753-761.

PMID: 38099011 PMC: 10718117. DOI: 10.4103/idoj.idoj_360_23.

Intralesional Purified Protein Derivative of Tuberculin Versus Intralesional Mycobacterium W Vaccine in Treatment of Recalcitrant Extragenital Warts: A Randomized, Single-Blinded, Comparative Study.

Mohta A, Jain S, Mehta R, Arora A Indian J Dermatol. 2022; 67(1):26-30.

PMID: 35656274 PMC: 9154150. DOI: 10.4103/ijd.ijd_521_21.

An Intention-to-Treat-Analysis of the Efficacy of Immunotherapy Using Mycobacterium W Vaccine and Purified Protein Derivative of Tuberculin for Warts With Assessment of Improvement in Quality of Life.

Mohta A, Sharma M, Kumari P, Ghiya B, Mehta R Dermatol Pract Concept. 2022; 12(2):e2022068.

PMID: 35646467 PMC: 9116529. DOI: 10.5826/dpc.1202a68.

A Randomized Comparative Study of MIP and MMR Vaccine for the Treatment of Cutaneous Warts.

Kaur A, Brar B, Kumar S, Brar S, Boparai A, Puri N Indian J Dermatol. 2021; 66(2):151-158.

PMID: 34188270 PMC: 8208270. DOI: 10.4103/ijd.IJD_700_20.